V
VIR
Vir Biotechnology, Inc.
9.50
-0.33-3.36%After Hours: 9.42 -0.08 -0.84%18:38 04/10 EDT
OPEN/PREV CLOSE9.87/9.83
TODAY RANGE9.42-9.90
VOL1.41M
MARKET CAP1.49B
52 WEEK RANGE4.155-10.94
AVG VOL (3M)3.55M
% TURNOVER0.90%
TURNOVER--
P/E (TTM)-3.0045
% RANGE4.93%
EPS(TTM)-3.1619
P/E(FORWARD)-7.1429
P/B1.731
BVPS5.49
DIVIDEND--
P/S19.33
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.20B
SHARES OUTSTANDING157.16M
NEXT EARNINGS05/05-05/11
FREE FLOAT126.52M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Reuters·13h ago
Vir Biotechnology CMO Mark Eisner to step down April 24
Simply Wall St·6d ago
Is Vir Biotechnology’s (VIR) Insider Selling After Its Capital Raise Reframing the Investment Narrative?
Simply Wall St·03/08 15:13
Why Vir Biotechnology (VIR) Is Up 5.1% After Astellas Cancer Deal And Equity Raise News
TipRanks·03/04 22:00
Vir Biotechnology Names CEO Marianne De Backer as President
Reuters·03/04 21:03
Vir Biotech Names CEO Marianne De Backer President
Benzinga·03/04 12:35
Semtech To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Wednesday
Simply Wall St·03/04 12:29
Assessing Vir Biotechnology (VIR) Valuation After Astellas Alliance And VIR-5500 Phase 1 Update
Dow Jones·03/04 12:11
Vir Biotechnology Is Maintained at Buy by HC Wainwright & Co.